SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001019056-23-000134
Filing Date
2023-02-14
Accepted
2023-02-14 07:21:03
Documents
2
Group Members
EVERSEPT 1 LLCEVERSEPT GLOBAL HEALTHCARE FUND, L.P.EVERSEPT GP, LLCEVERSEPT PARTNERS, L.P.KAMRAN MOGHTADERI

Document Format Files

Seq Description Document Type Size
1 SC 13G/A cabaletta_13ga1.htm SC 13G/A 140825
2 EXHIBIT A ex_a.htm EX-99.A 12894
  Complete submission text file 0001019056-23-000134.txt   155645
Mailing Address 444 MADISON AVENUE 22ND FLOOR NEW YORK NY 10022
Business Address 444 MADISON AVENUE 22ND FLOOR NEW YORK NY 10022 212-271-4200
Eversept Partners, LP (Filed by) CIK: 0001697013 (see all company filings)

IRS No.: 475115829 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Subject) CIK: 0001759138 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91178 | Film No.: 23622362
SIC: 2836 Biological Products, (No Diagnostic Substances)